Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials.
Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W. Ligueros-Saylan M, et al. Among authors: kothny w. Diabetes Obes Metab. 2010 Jun;12(6):495-509. doi: 10.1111/j.1463-1326.2010.01214.x. Diabetes Obes Metab. 2010. PMID: 20518805
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man.
Busch SJ, Hoffmann P, Sahota P, Johnson R, Kothny W, Meyer F, Foley JE. Busch SJ, et al. Among authors: kothny w. Diabetes Obes Metab. 2013 Jan;15(1):72-6. doi: 10.1111/j.1463-1326.2012.01678.x. Epub 2012 Sep 9. Diabetes Obes Metab. 2013. PMID: 22882290
37 results